All In MedTech

FDA Clearance Tracker · P150035-S003

Aveir DR Leadless System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 29, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplementBreakthrough

Decided

Jun 29, 2023

Approved

Time to decision

163 days

Received Jan 17, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P150035-S003
Device name
Aveir DR Leadless System
Applicant location
Sylmar, CA
Received
Jan 17, 2023
Decided
Jun 29, 2023
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P150035

Device type

Device class
Class III
Regulation
21 CFR 870.3610

Every decision under product code PNJ

FDA's approval statement

As written in FDA's record.

Approval for the Aveir DR Leadless System, Aveir Leadless Pacemaker (Right Ventricular), Aveir Leadless Pacemaker (Right Atrial), Aveir Delivery Catheter, Aveir Link Module.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.